Etanercept biosimilar (Biotrion) | Interleukin Related interleukin-related.com

Product Name :
Etanercept biosimilar (Biotrion)

Search keywords :
BTD

drugId :
null

Target Vo:
Tumor necrosis factor β

Target Vo Short Name :
TNFβ

Moa_Name:
Tumor necrosis factor β inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Biotrion

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Arthritis, Rheumatoid

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cyclin D1 Rabbit mAb Protocol
NLRP3 Rabbit mAb Biological Activity
Thioredoxin Antibody: Thioredoxin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to Thioredoxin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts